Adagene Inc. (ADAG) Financials

ADAG Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 133.6 million 27.6 million
March 31, 2026 78.3 million 42.9 million
Dec. 31, 2025 78.3 million 42.9 million
June 30, 2025 66.5 million 28.6 million

ADAG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.9 million ?
March 31, 2026 -4.6 million ?
Dec. 31, 2025 -4.6 million ?
June 30, 2025 -11.2 million 2.0 million

ADAG Net Income

No data available :(

ADAG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 127.9 million 1.0 million 183194
March 31, 2026 74.5 million - -
Dec. 31, 2025 74.5 million 1.1 million 145535
June 30, 2025 62.8 million - 88706

ADAG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 45.3 million
March 31, 2026 37.9 million
Dec. 31, 2025 59.2 million
June 30, 2025 37.7 million

ADAG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 156551 13.7 million 4.3 million -
March 31, 2026 14602 9.8 million - -
Dec. 31, 2025 14602 9.8 million 3.4 million -
June 30, 2025 2499 11.7 million 3.7 million -

ADAG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.6 million 256457
March 31, 2026 7.7 million 282320
Dec. 31, 2025 7.7 million 282320
June 30, 2025 - 300326

ADAG

Price: $2.29

52 week price:
1.30
4.85

Earnings Per Share: -0.37 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: China

Volume: 47600

Market Capitalization: 106.5 million

Links: